These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 7049782

  • 21. Necrobiosis lipoidica diabeticorum: platelet survival and response to platelet inhibitors.
    Quimby SR, Muller SA, Schroeter AL, Fuster V, Kazmier FJ.
    Cutis; 1989 Mar; 43(3):213-6. PubMed ID: 2707053
    [Abstract] [Full Text] [Related]

  • 22. Targeting the inflammatory response in secondary stroke prevention: a role for combining aspirin and extended-release dipyridamole.
    Weyrich AS, Skalabrin EJ, Kraiss LW.
    Am J Ther; 2009 Mar; 16(2):164-70. PubMed ID: 19300042
    [Abstract] [Full Text] [Related]

  • 23. Anti-platelet effects of 100 mg alternate day oral aspirin: a randomized, double-blind, placebo-controlled trial of regular and enteric coated formulations in men and women.
    Ridker PM, Hennekens CH, Tofler GH, Lipinska I, Buring JE.
    J Cardiovasc Risk; 1996 Apr; 3(2):209-12. PubMed ID: 8836865
    [Abstract] [Full Text] [Related]

  • 24. Treatment of claudication with dipyridamole and aspirin.
    Libretti A, Catalano M.
    Monogr Atheroscler; 1986 Apr; 14():207-9. PubMed ID: 3526127
    [No Abstract] [Full Text] [Related]

  • 25. Summary of ongoing clinical trials of platelet-active drugs in cardiovascular disease.
    Passamani ER.
    Circulation; 1980 Dec; 62(6 Pt 2):V106-10. PubMed ID: 7002348
    [Abstract] [Full Text] [Related]

  • 26. Aspirin and dipyridamole ineffective in treatment of necrobiosis lipoidica.
    Statham BN, Finlay AY, Marks R.
    N Engl J Med; 1980 Dec 11; 303(24):1419. PubMed ID: 7001236
    [No Abstract] [Full Text] [Related]

  • 27. Secondary prevention of stroke: does dipyridamole add to aspirin?
    Lowenthal A, Buyse M.
    Acta Neurol Belg; 1994 Dec 11; 94(1):24-34. PubMed ID: 8140884
    [Abstract] [Full Text] [Related]

  • 28. Effects of clopidogrel and aspirin in combination versus aspirin alone on platelet activation and major receptor expression in diabetic patients: the PLavix Use for Treatment Of Diabetes (PLUTO-Diabetes) trial.
    Serebruany VL, Malinin AI, Pokov A, Barsness G, Hanley DF.
    Am Heart J; 2008 Jan 11; 155(1):93.e1-7. PubMed ID: 18082496
    [Abstract] [Full Text] [Related]

  • 29. Trial of dipyridamole-aspirin in recurring venous thrombosis.
    Steele P.
    Lancet; 2008 Jan 11; 2(8208-8209):1328-9. PubMed ID: 6109150
    [Abstract] [Full Text] [Related]

  • 30. Drug utilization review: dipyridamole plus aspirin antiplatelet therapy.
    Crisp CB, Garrard EA.
    Hosp Formul; 1985 Nov 11; 20(11):1175-7, 1180-1, 1185. PubMed ID: 10274573
    [Abstract] [Full Text] [Related]

  • 31. Danqi Piantan Jiaonang does not modify hemostasis, hematology, and biochemistry in normal subjects and stroke patients.
    Gan R, Lambert C, Lianting J, Chan ES, Venketasubramanian N, Chen C, Chan BP, Samama MM, Bousser MG.
    Cerebrovasc Dis; 2008 Nov 11; 25(5):450-6. PubMed ID: 18417963
    [Abstract] [Full Text] [Related]

  • 32. Randomized clinical trial of the antiplatelet effects of aspirin-clopidogrel combination versus aspirin alone after lower limb angioplasty.
    Cassar K, Ford I, Greaves M, Bachoo P, Brittenden J.
    Br J Surg; 2005 Feb 11; 92(2):159-65. PubMed ID: 15609386
    [Abstract] [Full Text] [Related]

  • 33. Antiplatelet therapy for the prevention of recurrent stroke and other serious vascular events: a review of the clinical trial data and guidelines.
    Hankey GJ.
    Curr Med Res Opin; 2007 Jun 11; 23(6):1453-62. PubMed ID: 17559741
    [Abstract] [Full Text] [Related]

  • 34. Titrated initiation of acetylsalicylic acid-dipyridamole therapy reduces adverse effects and improves tolerance in patients with stroke.
    Douen AG, Medic S, Sabih M, Pageau N, Shuaib A.
    J Stroke Cerebrovasc Dis; 2008 Jun 11; 17(6):356-9. PubMed ID: 18984426
    [Abstract] [Full Text] [Related]

  • 35. Treatment with aspirin and dipyridamole is more effective than aspirin in reducing low shear blood viscosity.
    Rosenson RS.
    Microcirculation; 2008 Oct 11; 15(7):615-20. PubMed ID: 18788038
    [Abstract] [Full Text] [Related]

  • 36. Does increased platelet aggregation have a prognostic value in the deterioration of background diabetic retinopathy? The Damad Study Group.
    Plu G, Lecrubier C, Scarabin PY, Baudoin C, Samama M.
    Thromb Haemost; 1990 Oct 22; 64(2):202-5. PubMed ID: 2270529
    [Abstract] [Full Text] [Related]

  • 37. [Effect of acetylsalicylic acid and dipyridamole on the microcirculatory state of diabetes mellitus patients based on biomicroscopy and rheography data].
    Gendeleka GF, Gruzina EA.
    Vrach Delo; 1983 Nov 22; (11):76-9. PubMed ID: 6659464
    [No Abstract] [Full Text] [Related]

  • 38. [The therapeutical effect of dipyridamole on chronic glomerulonephritis and nephrotic syndrome in large dose administration--the study in a double blind group comparison method (author's transl)].
    Ishikawa H, Honjo A, Hayashi M, Hamaguchi T, Morita T, Tesutani T, Yamamoto M, Fujimoto Y, Okubo A, Oka G.
    Nihon Jinzo Gakkai Shi; 1979 Feb 22; 21(2):135-55. PubMed ID: 381736
    [No Abstract] [Full Text] [Related]

  • 39. Distribution of dipyridamole in blood components among post-stroke patients treated with extended release formulation.
    Serebruany V, Sabaeva E, Booze C, Atar OD, Eisert C, Hanley D, Aggrenox Compliance Task Force.
    Thromb Haemost; 2009 Sep 22; 102(3):538-43. PubMed ID: 19718475
    [Abstract] [Full Text] [Related]

  • 40. Editorial: Anticoagulation IV: Preventing thrombosis by modifying platelet behavior.
    Adelson E, Segal A.
    Med Ann Dist Columbia; 1974 Jun 22; 43(6):7-8. PubMed ID: 4526259
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.